University of Lisbon   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Lisbon Portugal (1290)

Organization Overview

First Clinical Trial
2005
NCT00353665
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Faculdade de Motricidade Humana - Universidade de Lisboa | Faculty of Human Kinetics, University of Lisbon | Grupo de Investigação em Bioquímica e Biologia Oral | Hospital de Santa Maria - Lisbon | Hospital de Santa Maria, Lisbon | Hospital Santa Maria, Lisbon, Portugal | Hospital Santa Maria, Portugal | Institute of Molecular Medicine | Northern Lisbon Hospital Center | Nova Medical School | Faculdade de Ciências Médicas - Universidade Nova de Lisboa | University of Lisbon

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amyotrophic Lateral Sclerosis (Phase 3)

Brain Death (Phase 2)

Cadaver (Phase 2)

Chorioamnionitis (Phase 3)

Death (Phase 2)

Endometritis (Phase 3)

Fetal Membranes, Premature Rupture (Phase 3)

Graft vs Host Disease (Phase 2)

Hypertrophy (Phase 2)

Hypertrophy, Left Ventricular (Phase 2)

Intracranial Thrombosis (Phase 3)

Meningitis (Phase 3)

Motor Neuron Disease (Phase 3)

Neonatal Sepsis (Phase 3)

Parkinson Disease (Phase 2)

Pneumonia (Phase 3)

Rupture (Phase 3)

Sclerosis (Phase 3)

Sinus Thrombosis, Intracranial (Phase 3)

Sjogren's Syndrome (Phase 4)

Syndrome (Phase 4)

Thrombosis (Phase 3)

Venous Thrombosis (Phase 3)

Xerostomia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial APIs: 24